Business Wire

LR Health & Beauty Celebrates Its 40th Anniversary

Share

Social Commerce Company has been giving sales partners and customers a better quality of life with high-quality product solutions for four decades

The Social Commerce Company LR Health & Beauty is looking back on 40 years of company history this year. The company, which was founded in 1985, has developed into a global player in the direct selling industry in recent years.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108836518/en/

null

LR Headquarters (Photo: Business Wire)

LR Health & Beauty has been setting innovative trends in the nutritional supplements and cosmetics sector for 40 years. The unique selling point: The products are sold by independent sales partners who earn an additional income by recommending products and setting up their own business. "LR stands for quality, innovation and a strong people business that offers an attractive business model to people who want more flexibility, more self-fulfilment and financial independence," explains CEO Dr. Andreas Laabs. "We are proud of the past years and thank our partners, customers and employees who have made this success possible."

Product solutions and business model at the cutting edge

The aim of the Ahlen-based direct selling company is to set new standards in the future, which will contribute to the further growth of the LR Group. LR Health & Beauty laid important foundations for this in 2024, both in terms of products and sales: in April, the Ahlen-based company launched the “LR Health Mission” intestinal metabolism treatment. The new decorative cosmetics line "LR ZEITGARD Signature" followed in September. Both launches will go down in LR history as two of the five most successful launches.

In terms of the business model, LR offers its sales partners a regulated, performance-based income if they meet the qualification criteria with the restructuring of the career plan in October 2024. This gives the LR partnership more security on the path to independence.

Four decades of success set standards for the future

In the course of its company history, LR has achieved numerous milestones. The company's most significant successes include the start of sales of nutritional supplements in 2000 and the success of the best-selling Aloe Vera Drinking Gel in 2002. In the same year, the new Ahlen headquarters on Kruppstraße were opened. Another highlight was the entry in the Guinness Book of Records (formation of the LR logo with 265 VW Polos; 2008) and the founding of the children's charity LR Global Kids Fund in 2009.

In 2015, the company was named the best European direct selling company of the year. The opening of the state-of-the-art aloe vera production facility followed in 2018, followed by the receipt of the "Business Award of the City of Ahlen" in 2019. With the introduction of the "Zeitgard Pro Cosmetic Device" in 2022, the intestinal metabolism treatment "LR Health Mission" in 2024 and the make-up line "ZEITGARD Signature", LR continues its success story.

One person who remembers these special events well is Managing Director Thomas Heursen. He started as an LR sales partner in 1990, quickly reached the career level of orgaleader and switched to the corporate side two years later. Thomas Heursen knows the LR business like no other and explains what LR's recipe for success is: "LR is always on the move and continues to develop without forgetting its roots. Close cooperation with our sales partners is important to us. We have successfully implemented this in recent years. With our product solutions and a business model that is in tune with the times, we are creating the ideal conditions for our partnership with LR to be as successful as possible."

LR Health & Beauty

The LR Group successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250108836518/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy9.1.2025 09:00:00 CET | Press release

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® (defatted powder of Arachis hypogaea L., semen (peanut)) for thetreatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers all 27 European member states and the three European Economic Area states (Iceland, Liechtenstein and Norway). This approval of the extension of indication of Palforzia® to toddlers, follows the July 2024 approval by the U.S. Food and Drug Administration (FDA). Palforzia® is the first and only EMA and FDA approved oral immunotherapy for toddlers with a confirmed diagnosis of peanut allergy. “Peanut allergy is one of the most frequent food allergies. Early intervention is crucial to reduce the risks of accidental exposure and may be very important in improving long-term outcomes. The approval of Palforzia for toddl

Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference9.1.2025 08:37:00 CET | Press release

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan’s 43rd Annual Healthcare Conference on Thursday, January 16, 2025. The company’s presentation will begin at 8:30 a.m. PT/11:30 am (Eastern Time). The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann Pick type C (NPC). Positive topline data reported earlier this year from the company’s successful Phase 2 study investigating nizubaglustat in GM2 and NPC patients demonstrated that the compound had a positive safety profile. Preliminary improvements or stabilization of clinical endpoints were observed in the majority of patients, highlighting encouraging early efficacy trends for the compound. Azafaros is preparing to initiate Phase 3 studies with nizubaglustat in

Kaneka Acquires EndoStream Medical Ltd.9.1.2025 06:21:00 CET | Press release

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) acquired 96.8% of shares of EndoStream Medical Ltd. (Headquarters: Or Akiva, Israel; CEO: Danel Mayer; hereinafter referred to as ESM), an Israeli medical equipment company, on December 23, 2024. By combining Kaneka's manufacturing and ESM's technology, we will jointly develop new medical devices, mainly for cerebrovascular treatment, in addition to the Nautilus™ device for aneurysm treatment currently under development. We aim to achieve sales of over 20 billion yen by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108226003/en/ Cerebral aneurysm treatment device “Nautilus™” (Graphic: Business Wire) ESM is a manufacturer of innovative technologies in the field of cerebrovascular diseases and is developing a device for the treatment of cerebral aneurysms called “Nautilus™” that can treat aneurysms with wide openings in cerebr

KRAFTON Showcases AI Model ‘CPC’ Built with NVIDIA ACE at CES 20259.1.2025 03:37:00 CET | Press release

Shaping the future of gaming with KRAFTON’s AI technology and NVIDIAHands-on demo features CPC technology applied to the PUBG IP Franchise and inZOI KRAFTON (CEO Changhan ‘CH’ Kim) set a new milestone for the global gaming industry with the introduction of ‘CPC’ (Co-Playable Character), an NPC (Non-Player Character) brought to life with generative AI, in collaboration with NVIDIA, at the world’s largest IT exhibition CES 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108628507/en/ Kangwook Lee, Head of the Deep Learning Division at KRAFTON (Photo: KRAFTON) On January 8, KRAFTON joined NVIDIA at the Fontainebleau Hotel in Las Vegas. KRAFTON showcased an innovative AI experience built with NVIDIA ACE technologies, presenting a bold vision for the future of gaming. Kangwook Lee, Head of the Deep Learning Division at KRAFTON, demonstrated CPC, describing it as “a groundbreaking character concept enabled by an on-device

SLB awarded multi-region deepwater contracts by Shell to support capital-efficient energy development8.1.2025 14:26:00 CET | Press release

SLB will use AI to enable repeatable delivery of consistent and cost-efficient wellsProjects will span across UK North Sea, Trinidad and Tobago, Gulf of Mexico and others Global energy technology companySLB (NYSE: SLB) has been awarded a series of major drilling contracts by Shell to support capital-efficient energy development across its deep- and ultra-deepwater assets in the UK North Sea, Trinidad and Tobago, the Gulf of Mexico and others. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108998944/en/ The projects, which will be delivered over a three-year timeframe, will combine SLB’s AI-enabled digital drilling capabilities with its expertise in ultra-deepwater environments. (Photo: Business Wire) The projects, which will be delivered over a three-year timeframe, will combine SLB’s AI-enabled digital drilling capabilities with its expertise in ultra-deepwater environments. This approach will help SLB to repeatably and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye